期刊文献+

循环肿瘤细胞检测对直肠癌同步放化疗的临床意义 被引量:3

Clinical significance of circulating tumor cells for chemo-radiotherapy in patients with rectal cancer
原文传递
导出
摘要 目的探讨外周血循环肿瘤细胞(CTCs)对直肠癌患者同步放化疗的临床意义。方法选取2014年6月至2015年12月间新疆医科大学第五附属医院收治的行同步放化疗的30例直肠癌患者为观察组,同时随机选取20例健康体检者为对照组。采用密度离心法及免疫荧光技术的方法,进行外周血循环肿瘤细胞检测,同时分析同步放化疗前后CTCs与患者临床特征的变化情况。结果直肠癌患者外周血中检出CTCs者18例,阳性检出率为76.2%;对照组患者中未检出CTCs,且CTCs阳性检出率与患者临床分期和淋巴结转移情况有关,差异均有统计学意义(均P<0.05)。结论CTCs与直肠癌患者的不良预后相关,提示直肠癌患者有较高的恶性风险及潜在转移风险。 Objective To explore the clinical significance of circulating tumor cells (CTCs) in the peripheral blood for patients with rectal cancer receiving ehemo-radiotherapy (CRT). Methods Thirty patients with rectal cancer who had received CRT in The Fifth Affiliated Hospital of Xinjiang Medical University from June 2014 to December 2015 were selected as the observation group and 20 healthy volunteers were selected as the control group. CTCs were detected using density-gradient eentrifugation and immunofluores- cence staining. The changes in CTCs level and clinical characteristics were also analyzed pre- and post- chemoradiotherapy. Results CTCs were detected in 18 patients, and the positive rate of CTCs in the peripheral blood for rectal cancer group was 76. 2% , while no tumor cell could be found in the control group. The positive rate of CTCs was significantly correlated with clinical stages and lymph node metastasis ( all P 〈 O. 05 ). Conclusion CTCs was associated with poor prognosis of rectal cancer, which predicted malignant eoloreetal risk and potential risk of metastasis.
出处 《中国肿瘤临床与康复》 2017年第3期284-287,共4页 Chinese Journal of Clinical Oncology and Rehabilitation
基金 新疆医科大学科研创新基金项目(XYDCX2014150)
关键词 直肠肿瘤 循环肿瘤细胞 同步放化疗 临床特征 Rectal neoplasm Circulating tumor ceils Chemo-radiotherapy Clinical charactenstms
  • 相关文献

参考文献3

二级参考文献91

  • 1李连弟,陈育德.中国恶性肿瘤死亡调查研究(1990-1992)[M].北京:人民卫生出版社.2008.
  • 2陈竺.全国第三次死因回顾抽样调查报告[M].北京:中国协和医科大学出版社,2008:11-12.
  • 3赫捷,陈万青.2012中国肿瘤登记年报[M].北京:军事医学科学出版社,2012:12-25.
  • 4SAUER R, BECKER H, HOHENBERGER W,et al.Preoperative versus postoperative chemoradiotherapy for rectalcancer [j] .N Engl J Med, 2004, 351(17): 1731-1740.
  • 5SAUER R, LIERSCH T,MERKEL S, et al. Preoperativeversus postoperative chemoradiotherapy for locally advancedrectal cancer: Results of the German CAO/ARO/AIO-94randomized phase ID trial after a median follow-up of 11 years[J] . J Clin Oncol, 2012,30(16): 1926-1933.
  • 6QUIRKE P, STEELE R, MONSON J, et al. Effect of theplane of surgery achieved on local recurrence in patients withoperable rectal cancer: a prospective study using data from theMRC CR07 and NCIC-CTG C016 randomized clinical trial[J] . Lancet, 2009, 373(9666): 821-828.
  • 7ROH M S, COLANGELO L H, O'CONNELL M J, et al.Preoperative multimodality therapy improves disease-freesurvival in patients with carcinoma of the rectum: NSABPR-03 [J] . J Clin Oncol, 2009, 27(31): 5124-5130.
  • 8COLLETTE L,BOSSET J F, DULK M D, et al. Patient withcurative resection of cT3-4 rectal cancer after preoperativeradiotherapy or radiochemotherapy: does anybody benefitfrom adjuvant fluorouracil-based chemotherapy. A trial of theEuropean Organization for Research and Treatment of CancerRadiation Oncology Group [ J ] . J Clin Oncol, 2007, 25(28):4379-4386.
  • 9BUJKO K, NOWACKI M P, NASIEROWSKA-GUTTMEJERA, et al. Sphincter preservation following preoperativeradiotherapy for rectal cancer: report of a randomized trialcomparing short-term radiotherapy vs. conventionallyfractionated radiochemotherapy [ J ] . Radiother Oncol, 2004,72(1): 15-24.
  • 10BUJKO K, NOWACKI M P, NASIEROWSKA-GUTTMEJERA, et al. Long-term results of a randomized trial comparingconventionally fractionated chemoradiation for rectal cancer[J] .BrJSurg, 2006, 93(10): 1215-1223.

共引文献231

同被引文献36

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部